Kids develop “werewolf syndrome” after being given mislabeled medicine
At least 17 children in Spain developed a form of “werewolf syndrome” after they were given mislabeled medication. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 29, 2019 Category: Pharmaceuticals Source Type: news
Report: Purdue looking to reach massive opioid settlement
With about 2,000 opioid-related lawsuits looming around the country, Purdue Pharma is reportedly offering to settle for $10-12 billion. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 28, 2019 Category: Pharmaceuticals Source Type: news
FDA widens generic drug recall probe beyond heart meds
The FDA is reportedly expanding its investigation related into impurities found in a class of blood pressure medications. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 28, 2019 Category: Pharmaceuticals Source Type: news
FDA fast tracks AstraZeneca diabetes drug
Farxiga is being given a speedy review prevent heart and kidney failure prevention for those with chronic kidney disease (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 27, 2019 Category: Pharmaceuticals Source Type: news
Boehringer pharma head to step down
Allan Hillgrove, the board member responsible for the company ' s human pharma and biopharma business, is set to retire at the end of the year as the rest of the Boehringer Ingelheim board is getting shaken up (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 27, 2019 Category: Pharmaceuticals Source Type: news
Oklahoma judge rules against J & amp;J in landmark trial
A judge in Oklahoma has ordered Johnson& Johnson to pay $572 million in damages for its role in the opioid epidemic. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 27, 2019 Category: Pharmaceuticals Source Type: news
Blockbuster-bound Lilly drug wins another FDA nod
Eli Lilly ’s Taltz has been given the go-ahead for a new indication, which could help propel the drug to blockbuster status. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 27, 2019 Category: Pharmaceuticals Source Type: news
FibroGen CEO passes away unexpectedly
FibroGen announced that Thomas B. Neff, Chief Executive Officer and Chairman of the Board of Directors of FibroGen, passed away unexpectedly this past weekend. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 26, 2019 Category: Pharmaceuticals Source Type: news
Amgen to buy Celgene ’s Otezla for $13.4B
Amgen has agreed to buy Celgene ’s psoriasis treatment for $13.4 billion in cash, in a deal that will pave the way for Bristol-Myers Squibb to complete its acquisition of Celgene. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 26, 2019 Category: Pharmaceuticals Source Type: news
New tuberculosis vax could improve protection
Australian researchers have successfully developed and tested a new type of vaccine targeting tuberculosis. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 23, 2019 Category: Pharmaceuticals Source Type: news
Pfizer gets priority review for cancer drug label expansion
Pfizer and partner Astellas announced that the FDA has accepted the supplemental New Drug Application looking for label expansion of cancer drug, Xtandi and granted priority review designation. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 23, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 8/23/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 23, 2019 Category: Pharmaceuticals Source Type: news
BIO 2019: It starts with one
This year ' s conference showed how incremental investments can make a global impact (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 22, 2019 Category: Pharmaceuticals Source Type: news
Today's solid dose drugs: High potency, high stakes
Exploring best-practice manufacturing strategies for highly potent oral solid dosage forms (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 21, 2019 Category: Pharmaceuticals Source Type: news
Pfizer makes $500M play in gene therapy market
Pfizer is injecting $500 million into a manufacturing facility in Sanford, North Carolina to position itself as a bigger player in the gene therapy market. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - August 21, 2019 Category: Pharmaceuticals Source Type: news
